Who is sponsoring NCT05211453?

NCT05211453 is sponsored by East Sussex Hospitals NHS Trust.

What drugs are being tested in NCT05211453?

Interventions in NCT05211453: atrioventricular node ablation.

What condition does NCT05211453 study?

NCT05211453 studies Atrial Fibrillation.

Is NCT05211453 still recruiting?

NCT05211453 is currently status unknown. Last updated 27 January 2022.

Last reviewed 2022-01-27 · How we verify

NCT05211453

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Randomised Comparison of Left and Right Sided Approaches to Ablation of the Atrioventricular Junction

Status unknown NA Last updated 27 January 2022

What this trial tests

NA trial testing atrioventricular node ablation in Atrial Fibrillation in 100 participants. Status unknown.

Timeline

1 November 2020

Primary endpoint
1 November 2022

1 November 2022

Quick facts

Lead sponsor	East Sussex Hospitals NHS Trust
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	100
Start date	1 November 2020
Primary completion	1 November 2022
Estimated completion	1 November 2022
Sites	1 location across United Kingdom

Drugs / interventions tested

atrioventricular node ablation

Conditions studied

Atrial Fibrillation — all drugs for Atrial Fibrillation →

Sponsor

East Sussex Hospitals NHS Trust

Who can join

18 and older, any sex, with Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will compare right sided atrioventricular node ablation to left sided atrioventricular node ablation

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of atrioventricular node ablation

Trials testing the same drug.

NCT06833138 — Atrioventricular Node Ablation and Conduction System Pacing in Patients With Well Controlled Permanent Atrial Fibrillati · NA · recruiting

Other recruiting trials for Atrial Fibrillation

Currently open trials in the same condition.

NCT07429214 — A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF · NA · recruiting
NCT07271238 — Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures · NA · recruiting
NCT07388108 — Atrial Dyssynchrony to Predict Arrhythmias in the Postoperative Setting of Cardiovascular Surgery. · recruiting
NCT07428967 — AV Node Ablation and CONDUCTion System Pacing for Atrial Fibrillation With Preserved Left Ventricular Function · NA · recruiting
NCT06650995 — AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure · NA · recruiting

Other East Sussex Hospitals NHS Trust trials

Trials by the same sponsor.

NCT04272762 — A Randomized Sham-controlled Study of Pulmonary Vein Isolation in Symptomatic Atrial Fibrillation · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05211453 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by East Sussex Hospitals NHS Trust
Last refreshed: 27 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05211453.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing